Telehealth Insomnia Prescribing: What Psychiatric NPs Can Do in Texas

If you’re a psychiatrist or PMHNP treating insomnia, you’ve likely wondered: Can I legally prescribe sleep medications via telehealth? What about controlled substances like Ambien? Do I need an in-person visit first?

The short answer: Yes, you can prescribe most insomnia medications via telehealth right now — including Schedule IV controlled substances like zolpidem and eszopiclone — without requiring an initial in-person exam. Federal flexibilities extended through December 31, 2025 allow this nationwide. But state-specific rules, your provider type, and upcoming regulatory changes will shape how you practice.

Here’s what you need to know to prescribe insomnia meds remotely in 2026, broken down by what psychiatrists vs PMHNPs can do, which states make it easier or harder, and how telehealth economics actually work.

What Psychiatrists Can Prescribe for Insomnia via Telehealth

Psychiatrists (MD/DO) have full prescribing authority in all 50 states. You can evaluate a patient via video, diagnose insomnia or a related sleep disorder, and prescribe any indicated medication — including all controlled substances — without legal supervision requirements.

For insomnia specifically, this means:

• Schedule IV hypnotics (zolpidem/Ambien, eszopiclone/Lunesta, temazepam) — fully prescribable via telehealth
• Off-label options (trazodone, low-dose doxepin, mirtazapine) — no restrictions
• Newer agents (suvorexant/Belsomra, lemborexant/Dayvigo) — same rules apply
• Benzodiazepines for insomnia with comorbid anxiety — your clinical judgment

The main constraint is state licensure: you must hold an active medical license in the state where the patient is physically located during the visit. If you’re treating patients in California, Texas, and New York, you need three separate licenses (though the Interstate Medical Licensure Compact can expedite this for member states like Texas and Illinois).

Federal controlled substance rules: The DEA extended COVID-era flexibilities allowing telehealth prescribing of Schedule II-V controlled substances without a prior in-person visit through December 31, 2025. This means you can initiate zolpidem for a new insomnia patient you’ve never met in person — legally and nationwide — as long as you conduct a proper video evaluation and use sound clinical judgment.

What happens after 2025? The DEA is expected to finalize permanent telemedicine prescribing rules. The proposed framework may require either:

• An in-person visit within 6-12 months for patients on chronic controlled substances, OR
• A special DEA telemedicine registration

Stay alert for final rules, but for now, standard practice applies: document the encounter thoroughly, obtain patient consent for telehealth, check your state’s PDMP before prescribing controlled meds, and use a DEA-compliant e-prescribing system.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What PMHNPs Can Prescribe: State-by-State Reality

PMHNPs are advanced practice nurses specializing in psychiatric care — but unlike psychiatrists, your prescribing authority varies dramatically by state. Some states grant you full autonomy to practice like an MD; others require ongoing physician supervision.

Full Practice States: You’re Essentially Independent

In 27 states plus DC, experienced PMHNPs can evaluate, diagnose, and prescribe (including controlled substances) without physician oversight. Key priority states:

California: AB 890 created a pathway to independent NP practice. As of 2023, you can work as a ‘103 NP’ (in a physician group setting with protocols) and after 3 years transition to ‘104 NP’ status — fully independent practice within your psych specialty by 2026. An experienced PMHNP treating insomnia in California can prescribe zolpidem, manage follow-ups, and coordinate CBT-I referrals entirely solo once they achieve 104 status.

New York: NPs with 3,600+ practice hours (roughly 2 years full-time) can practice completely independently — no collaborative physician agreement needed. You can run a telehealth insomnia clinic in New York, prescribe controlled sleep meds, and bill insurers directly without an MD’s signature.

Illinois: After completing 4,000 supervised hours plus 250 CE credits in your specialty, you qualify for Full Practice Authority. An experienced IL PMHNP can prescribe insomnia medications independently, though Illinois law requires physician consultation if prescribing Schedule II drugs beyond 30 days (rarely an issue for insomnia, which typically uses Schedule IV).

In these states, your scope mirrors a psychiatrist’s for insomnia treatment. You still need state APRN licensure, DEA registration for controlled substances, and PDMP access — but no formal physician oversight.

Reduced Practice States: Collaboration Required Initially

New York (for new NPs under 3,600 hours): You need a written collaborative agreement with a physician, though day-to-day supervision isn’t required. The agreement outlines your scope; you prescribe under your own authority but maintain the legal tie for liability and consultation.

Illinois (before FPA): Similarly, new NPs must collaborate with a physician who delegates prescriptive authority. You can treat insomnia and prescribe Schedule IV sleep meds, but your collaborating physician must be available for consults and periodic chart reviews.

In reduced practice states, telehealth platforms often help arrange collaborating physicians, but it’s an extra administrative layer compared to full practice states.

Restricted Practice States: Ongoing Supervision Mandatory

Texas, Florida, and Pennsylvania impose the strictest limits:

Texas: You must have a Prescriptive Authority Agreement with a Texas physician to prescribe anything. The law mandates:

• Written agreement filed with the medical board
• Monthly quality assurance meetings between you and your supervising physician
• Periodic chart reviews

Texas allows physicians to delegate Schedule III-V prescribing (zolpidem is Schedule IV, so you’re covered), but Schedule II drugs cannot be prescribed by NPs in outpatient settings — they’re limited to hospital-based or hospice care. For insomnia, this isn’t usually a barrier, but it means you can’t prescribe stimulants for comorbid narcolepsy without physician involvement.

Practical reality: If you’re a PMHNP joining a telehealth platform in Texas, the platform needs to provide (or help you secure) a supervising psychiatrist. This adds overhead but is standard practice for Texas-based tele-mental health companies.

Florida: Psychiatric NPs are excluded from Florida’s ‘autonomous practice’ law that applies to primary care NPs. You need a physician supervision agreement and protocol filed with the Board of Nursing. Florida also restricts NPs to 7-day supplies of Schedule II controlled substances (extended courses require physician sign-off), and only psychiatric NPs can prescribe controlled psychotropics to minors.

For insomnia (typically Schedule IV meds), you can prescribe under protocol, but you’re operating with more physician involvement than independent practice states. Florida’s telehealth law does allow out-of-state providers to register and practice remotely, which can expand opportunities if you’re licensed elsewhere.

Pennsylvania: Requires NPs to have collaborative agreements with two physicians (one of the most restrictive setups nationally). PA law also limits prescribing:

• Schedule II: max 30-day supply before physician re-evaluation
• Schedule III/IV: max 90-day supply before physician involvement

This directly affects insomnia care: you could prescribe 3 months of zolpidem, then the patient must be seen by (or at least discussed with) the supervising physician for continuation. Many PMHNPs in PA find this cumbersome for chronic insomnia management.

Key takeaway: If you’re a PMHNP, check your state’s scope of practice laws carefully. Full practice states offer the autonomy to build a robust telehealth insomnia practice; restricted states require physician partnerships that add administrative complexity and may limit your independence.

Telehealth Prescribing Rules: Federal and State

Federal Rules (DEA Controlled Substance Flexibilities)

Historically, the Ryan Haight Act required an in-person exam before prescribing controlled substances via telemedicine. COVID-19 emergency waivers suspended this, and the DEA has repeatedly extended the flexibility — most recently through December 31, 2025.

What this means for you:

• You can prescribe zolpidem, eszopiclone, temazepam, or other Schedule IV insomnia meds via telehealth to new patients you’ve never met in person
• This applies nationwide for properly licensed providers
• You must conduct a legitimate medical evaluation (typically video) and use sound clinical judgment
• Standard controlled substance rules apply: DEA registration, e-prescribing via EPCS-compliant systems, PDMP checks

After December 31, 2025, expect new DEA rules. The likely outcome is either:

• A permanent telemedicine prescribing pathway with specific requirements (possibly an in-person visit within 6-12 months for chronic controlled substance patients), OR
• A special DEA telemedicine registration

For now, plan conservatively: document encounters thoroughly, follow state PDMP requirements, and stay informed on DEA updates.

State-Specific Telehealth and Prescribing Rules

Florida: Telehealth law prohibits prescribing Schedule II controlled substances via telemedicine except for psychiatric disorders (plus a few other exceptions like hospice). Since insomnia is a psychiatric condition, you’re legally allowed to prescribe Schedule II if clinically appropriate — though in practice, most insomnia meds are Schedule IV, so this rarely applies. Florida also requires e-prescribing for all controlled substances (no paper scripts).

Texas: Requires a valid patient-practitioner relationship established via appropriate telehealth exam. Texas aligns with federal DEA rules on controlled substances. As long as federal flexibilities are in place, you can prescribe controlled insomnia meds via telehealth. Texas law also mandates PDMP checks before prescribing opioids, benzodiazepines, or barbiturates — so if you’re prescribing a benzodiazepine for insomnia with comorbid anxiety, check the Texas PDMP first.

California: No unique state ban on telehealth prescribing of controlled substances beyond federal rules. Providers must register with CURES (California’s PDMP) and check it every 4 months for patients on ongoing controlled prescriptions. California is telehealth-friendly with strong parity laws requiring insurers to cover telehealth visits at the same rate as in-person.

New York: Mandates checking the I-STOP PDMP for every controlled substance prescription (Schedule II-IV) — a strict requirement. Providers must document the PDMP check within 24 hours before prescribing. New York also has robust telehealth support: insurers must cover tele-mental health, and Medicaid reimburses video and even audio-only visits for behavioral health.

Pennsylvania: No specific state telehealth restrictions on controlled substance prescribing beyond federal DEA rules, but PA lacks a comprehensive telehealth parity law. Coverage depends on insurer, though many follow national trends and reimburse tele-psychiatry.

Illinois: Requires PDMP checks for opioids and benzodiazepines; insomnia meds like zolpidem aren’t explicitly mandated, but best practice is to check all controlled substances. Illinois enacted permanent telehealth payment parity in 2021, requiring private insurers to reimburse telehealth at the same rate as in-person — a major win for providers.

Prescription Drug Monitoring Programs (PDMPs)

Nearly every state requires checking the PDMP before prescribing controlled substances. For insomnia prescribers, this means:

• First-time prescriptions: Always check the PDMP to see if the patient is already receiving sleep meds, benzodiazepines, or opioids from other providers
• Ongoing prescriptions: Periodic checks (frequency varies by state — some mandate every 3-4 months)
• Multi-state practice: If you’re licensed in multiple states, you need access to each state’s PDMP system (which can mean multiple logins and sometimes proxy arrangements)

This adds administrative steps but is non-negotiable for compliance and patient safety. Many telehealth platforms integrate PDMP checks into workflows.

What Insomnia Prescribing Actually Looks Like in Telehealth

Typical workflow:

1. Initial video consultation (20-30 minutes): Gather sleep history (ideally the patient completes a sleep questionnaire or 2-week sleep diary beforehand), assess mental health and medical contributors, review current medications, discuss risks/benefits of pharmacotherapy vs behavioral interventions.

2. Clinical decision: If medication is indicated, obtain patient consent for telehealth treatment and discuss medication choice. For new insomnia cases, you might start with:

• Zolpidem 5-10 mg (short-acting, good for sleep onset insomnia)
• Trazodone 50-100 mg (off-label, sedating antidepressant, non-controlled)
• Low-dose doxepin 3-6 mg (antihistamine effect, FDA-approved for insomnia)
• Eszopiclone 1-3 mg (longer-acting, good for sleep maintenance)

1. E-prescribe: Send prescription to patient’s pharmacy via EPCS-compliant platform. Document the visit, including patient location, consent for telehealth, clinical rationale, and PDMP check results if prescribing a controlled substance.

2. Follow-up (2-4 weeks): Short video visit (15-20 minutes) to assess efficacy and side effects. Did sleep latency improve? Any next-day drowsiness, sleep-walking, or cognitive effects? Decide whether to continue, adjust dose, or try an alternative.

3. Ongoing management: For chronic insomnia, guidelines emphasize behavioral interventions (CBT-I) as first-line long-term treatment. Many telehealth providers coordinate referrals to digital CBT-I programs or therapists while managing short-term pharmacotherapy. The goal is often to taper medications once sleep improves with behavioral changes.

Key clinical considerations:

• Tolerance and dependence: Patients may request dose increases of benzodiazepines or Z-drugs; have frank discussions about tolerance and explore alternatives (e.g., switching to non-controlled options like trazodone or melatonin).
• Comorbidities: Insomnia often coexists with depression, anxiety, or chronic pain. Addressing the underlying condition (e.g., starting an SSRI for depression) may improve sleep without needing dedicated hypnotics.
• Fall risk in elderly: Be cautious prescribing sedatives to older adults (increased fall/fracture risk). Consider low-dose doxepin or ramelteon (melatonin agonist, non-controlled).
• Sleep apnea screening: Ask about loud snoring, witnessed apneas, or excessive daytime sleepiness — undiagnosed sleep apnea can worsen with sedatives. Refer for sleep study if suspected.

Documentation requirements: Most states expect the same standard of care for telehealth as in-person. Document:

• Patient consent for telehealth
• Patient’s physical location during visit
• Clinical evaluation findings
• PDMP check (if prescribing controlled substance)
• Treatment plan and patient education provided

Many malpractice carriers require no special addendums for telehealth if you follow these standards.

Reimbursement: Will You Actually Get Paid?

Short answer: Yes, and usually at the same rate as in-person visits.

Medicare Reimbursement

Medicare covers tele-mental health services nationwide (extended through at least 2024, with Congress showing support for making this permanent). Psychiatrists and PMHNPs can bill standard E/M codes for medication management visits:

• CPT 99213 (15-20 minute established patient visit): ~$95 national average
• CPT 99214 (25-30 minute visit): ~$125 national average

These rates apply whether the visit is in-person or via video. Medicare also covers audio-only psychiatric services in some cases for patients who cannot do video.

Future consideration: Medicare proposed requiring an in-person visit within 6 months before continuing telehealth-only mental health treatment, with annual in-person check-ins thereafter. Enforcement has been delayed, and many expect this rule will be revised or eliminated given high utilization of tele-psychiatry. Stay updated on CMS policy.

Private Insurance and State Parity Laws

24 states plus DC have enacted telehealth payment parity laws requiring private insurers to reimburse telehealth services at the same rate as in-person visits. Key states:

• California: Strong parity law since 1996; insurers must cover telehealth equivalently
• Illinois: Permanent payment parity enacted 2021 — you get paid the same for tele-visits
• New York: Parity in coverage and cost-sharing; many insurers voluntarily pay at parity
• Texas: Coverage parity mandated; new 2026 law expands coverage for out-of-state telehealth providers (if they’re Texas-licensed)
• Pennsylvania: No comprehensive parity law, but many insurers follow national trends and reimburse tele-mental health competitively due to network adequacy needs
• Florida: Coverage parity required by 2016 law, but not explicit payment parity — left to insurer discretion; most major insurers reimburse tele-mental health at parity

Practical takeaway: In most states, you can expect to earn $90-150 per medication management visit for insomnia care, whether delivered in-person or via video. Psychiatrists generally have an easier time getting credentialed with insurance panels due to specialty shortages. PMHNPs are also in demand and increasingly credentialed independently (though some insurers may require billing under a physician in restricted practice states).

Cash-Pay Alternative

Some telehealth platforms operate on a direct-pay model, charging patients $75-150 per visit. This simplifies billing (no insurance hassles) but may limit your patient pool to those who can afford out-of-pocket costs. However, many patients with high-deductible plans prefer transparent cash pricing over fighting insurance pre-authorizations.

State-by-State Summary for Priority Markets

Why Join a Telehealth Platform vs DIY Marketing?

Let’s talk economics honestly.

Many providers consider marketing their own practice: building a website, investing in SEO, running Google Ads, listing on directories like Psychology Today or Zocdoc. The pitch is simple: acquire patients cheaply and keep all the revenue.

The reality is different:

The True Cost of DIY Patient Acquisition

SEO takes 6-12 months of consistent investment (content creation, technical optimization, backlinks) before generating meaningful patient flow. Most solo providers don’t have the expertise or patience for this. You’ll likely hire an agency at $1,500-3,000/month with no guarantee of results.

Google Ads for mental health keywords cost $15-40+ per click. Most clicks don’t convert to booked patients. Factor in:

• Ad spend testing and optimization
• Landing page development
• Staff time to handle and qualify leads
• No-show rates from cold leads (people who clicked an ad aren’t as committed as matched referrals)

Realistic cost per booked patient through Google Ads: $200-400+ when you account for all costs.

Psychology Today and Zocdoc charge monthly fees ($30-50/month for PT, higher for Zocdoc premium) plus you compete with hundreds of other providers on the same search page. Zocdoc charges $35-100+ per booking depending on specialty and market. Total monthly cost including subscription adds up fast, and conversion rates vary wildly.

Bottom line: If you’re spending $3,000-5,000/month on marketing with uncertain results, you’re gambling on channels that may or may not deliver qualified patients.

The Klarity Health Model: Pay Only When You See Patients

Klarity uses a pay-per-appointment model similar to Zocdoc, but with key advantages:

• No upfront marketing spend or monthly subscription fees — you pay a standard listing fee per new patient lead who books with you
• Pre-qualified patients already matched to your specialty and availability (not cold clicks from Google Ads)
• No wasted ad spend on traffic that doesn’t convert — you only pay when a qualified patient actually books
• Built-in telehealth infrastructure — no separate platform costs for video, scheduling, or EHR
• Both insurance and cash-pay patient flow — Klarity handles credentialing and billing complexity
• You control your schedule — set your availability, take time off, scale up or down without fixed costs

The economic case: Instead of gambling $3,000-5,000/month on marketing that may generate zero booked patients, you pay only when you see patients. That’s guaranteed ROI vs throwing money at uncertain channels.

Who benefits most:

• New providers building a practice without capital to burn on marketing experiments
• Established providers scaling their telehealth practice without hiring marketing staff
• Part-time providers who want patient flow without the overhead of maintaining paid ad campaigns

DIY marketing can eventually be cost-effective if you have the budget, expertise, and patience. But for most providers — especially those starting out or scaling quickly — a platform that handles patient acquisition removes the risk entirely.

FAQ: Insomnia Prescribing via Telehealth

Can I prescribe Ambien (zolpidem) via telehealth to a new patient I’ve never met in person?

Yes, as of 2026, federal DEA flexibilities (extended through December 31, 2025) allow prescribing Schedule IV controlled substances like zolpidem via telehealth without a prior in-person visit. You must conduct a legitimate video evaluation, obtain patient consent, check your state’s PDMP, and document appropriately. Both psychiatrists and eligible PMHNPs (depending on state scope) can do this.

Do I need a DEA registration to prescribe insomnia medications via telehealth?

Yes, if you’re prescribing controlled substances (zolpidem, eszopiclone, temazepam, benzodiazepines), you need a DEA registration. For non-controlled insomnia meds like trazodone or low-dose doxepin, DEA registration isn’t required, but you still need to be licensed in the patient’s state and follow standard prescribing rules.

What happens if the DEA requires in-person visits after 2025?

Stay tuned for final DEA rules. If they require an in-person visit within 6-12 months for patients on chronic controlled substances, telehealth platforms will likely help coordinate local in-person exams (perhaps with partner clinics) to maintain compliance. For now, plan ahead: document encounters thoroughly and follow best practices to minimize disruption if regulations change.

Can PMHNPs in Texas prescribe insomnia medications via telehealth?

Yes, but Texas PMHNPs need a Prescriptive Authority Agreement with a supervising physician. The physician delegates prescribing of Schedule III-V drugs (zolpidem is Schedule IV, so it’s covered). You cannot prescribe Schedule II drugs outpatient in Texas as an NP. Telehealth platforms operating in Texas typically provide or help arrange supervising physicians.

Do I need separate state licenses to practice telehealth in multiple states?

Yes. You must hold an active license in every state where your patients are physically located during telehealth visits. The Interstate Medical Licensure Compact (IMLC) expedites multi-state licensure for physicians (members include Texas, Illinois, Pennsylvania). NPs currently need individual state APRN licenses, though an APRN Compact is in development.

How do I check a state’s PDMP if I’m licensed in multiple states?

Each state has its own PDMP system (e.g., CURES in California, I-STOP in New York). You’ll need to register for access in each state where you prescribe controlled substances. Some states allow delegate access (e.g., your staff can check on your behalf). Telehealth platforms often integrate PDMP checks into workflows or provide guidance on registration.

Can I prescribe benzodiazepines for insomnia with comorbid anxiety via telehealth?

Yes, if clinically appropriate. Benzodiazepines (like temazepam or clonazepam) are Schedule IV controlled substances, so the same telehealth prescribing rules apply. Exercise caution with long-term benzodiazepine prescribing due to dependence risk — consider alternatives like SSRIs/SNRIs for underlying anxiety or non-controlled sleep aids.

What’s the difference between treating insomnia and other psychiatric conditions via telehealth?

Insomnia treatment often involves short-term medication use and frequent reassessment (2-4 week follow-ups initially), whereas conditions like depression or ADHD typically involve longer-term pharmacotherapy. Insomnia guidelines emphasize behavioral interventions (CBT-I) as first-line long-term therapy, so providers often coordinate therapy referrals alongside medication management. Additionally, ruling out sleep apnea or other medical causes may require in-person sleep studies or specialist referrals.

Do insurance companies pay the same for telehealth insomnia visits as in-person?

In most states, yes. 24 states plus DC mandate telehealth payment parity, requiring private insurers to reimburse telehealth at the same rate as in-person. Medicare also covers tele-mental health at parity. Even in states without explicit parity laws, many insurers pay similarly due to network adequacy needs and competitive pressure. Expect $90-150 per visit for medication management.

Can I use audio-only (phone) visits to prescribe insomnia medications?

It depends. Some states and insurers allow audio-only mental health visits (especially for established patients or those lacking video access), but many require video for controlled substance prescribing to meet standard of care. Best practice: use video for initial evaluations and when prescribing controlled substances; audio-only may be acceptable for follow-ups in some circumstances. Check state telehealth laws and insurer policies.

Next Steps: Start Treating Insomnia Patients via Telehealth

If you’re a psychiatrist or PMHNP looking to expand your practice or build a telehealth-focused insomnia clinic, the regulatory environment is favorable in most states — and the patient demand is massive. Millions of Americans struggle with insomnia, and access to psychiatric prescribers remains limited.

Before you start:

1. Verify your state’s scope of practice rules (especially if you’re a PMHNP in a restricted state)
2. Ensure you’re licensed in every state where you’ll treat patients
3. Register for DEA and each state’s PDMP system
4. Choose a telehealth platform that handles patient acquisition, credentialing, billing, and compliance

Consider joining Klarity Health’s provider network:

Klarity connects psychiatrists and PMHNPs with pre-qualified patients seeking insomnia treatment and other psychiatric care. Instead of spending months and thousands of dollars on uncertain marketing, you pay only when you see patients. The platform handles:

• Patient matching and scheduling
• Insurance credentialing and billing (or cash-pay processing)
• Telehealth infrastructure (video, EHR, e-prescribing)
• Compliance support for multi-state practice

You control your schedule and focus on what you do best: evaluating patients and providing evidence-based treatment.

Explore Klarity Health’s provider opportunities and start treating insomnia patients this week — without the marketing headaches or financial risk of going solo.

Sources and References

1. NursePractitionerOnline.com – Nurse Practitioner Practice Authority Updates (2025)
   www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates

2. Texas Medical Board – Prescribing and Supervision Guidelines
   www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision

3. California Board of Registered Nursing – AB 890 Implementation
   www.rn.ca.gov/practice/ab890.shtml

4. Rivkin Rounds Law Blog – New Law Allows Experienced NPs to Practice Independently in NY (April 13, 2022)
   www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny

5. Commonwealth Foundation – Nurse Practitioner Reform: Full Practice Authority in Pennsylvania (December 5, 2022)
   commonwealthfoundation.org/research/nurse-practitioner-reform-full-practice-authority-pennsylvania

6. USA Doctor Network – How to Get Insomnia Prescriptions via Telemedicine (June 11, 2025)
   usadocnetwork.com/how-to-get-insomnia-prescriptions-via-telemedicine-3

7. Center for Connected Health Policy – State Telehealth Laws and Reimbursement Policies Report (Fall 2025)
   www.cchpca.org/resources/state-telehealth-laws-and-reimbursement-policies-report-fall-2025

8. Medicare Physician Fee Schedule – CPT Code 99213 and 99214 Reimbursement (2026)
   www.medfeeschedule.com/code/99213 and www.medfeeschedule.com/code/99214

9. Florida Legislature – Telehealth Registration Statute (456.47)
   [www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html](https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html

Source:

• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=physician
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=Do%20I%20need%20to%20have,to%20a%20prescriptive%20authority%20agreement
• https://commonwealthfoundation.org/research/nurse-practitioner-reform-full-practice-authority-pennsylvania/#:~:text=expansive%20prescriptive%20authority%20is%20essential,survey%20of%20members%20of%20the
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=With%20sufficient%20experience%2C%20however%2C%20CNPs,250%20additional%20continuing%20education%20units
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=In%20September%202020%2C%20Governor%20Gavin,Chapter%20481%2C%20Statutes%20of%202024
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=match%20at%20L153%20For%20a,meetings%20must%20at%20a%20minimum
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=%E2%80%9CUnder%20HB%20607%2C%20psychiatric,%E2%80%9D
• https://usadocnetwork.com/how-to-get-insomnia-prescriptions-via-telemedicine-3#:~:text=Recent%20regulatory%20updates%20have%20introduced,evaluations%20until%20December%2031%2C%202025